文献速递甲状腺疾病

基于细针穿刺细胞学与韩国甲状腺影像报告和数据系统的细胞学-超声风险分层评分系统

Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.
PubMed 文献 · Thyroid · 2017-05-19

该回顾性研究纳入1651个≥1 cm甲状腺结节,基于细针穿刺细胞学与韩国甲状腺影像报告和数据系统(K-TIRADS)构建细胞学-超声(CU)评分系统,将恶性风险分为四级:极低危<3%、低危≥3%且<30%、高危≥30%且<90%、极高危≥90%。作者认为该CU评分系统可能有助于细针穿刺后的甲状腺结节管理。

要点

  • CU评分将结节恶性风险分为极低危<3%、低危≥3%且<30%、高危≥30%且<90%、极高危≥90%四级。
  • 在非诊断性、良性及意义未明的不典型细胞学结节中,K-TIRADS 3显著降低恶性风险。
  • 在非诊断性、良性及意义未明的不典型细胞学结节中,K-TIRADS 5显著增加恶性风险。

核心结论

  • 甲状腺结节的恶性风险可通过基于细针穿刺细胞学和K-TIRADS的CU风险分层系统进行分层。
  • 作者认为所提出的CU评分系统可能有助于细针穿刺后的甲状腺结节管理。

研究设计与样本

  • 回顾性研究,经机构审查委员会批准,纳入1651个≥1 cm且有最终诊断的甲状腺结节。
  • 评估细针穿刺细胞学与K-TIRADS联合结果的恶性风险,以开发CU系统。
  • 采用二项检验研究细针穿刺细胞学与超声模式(K-TIRADS)在结节恶性风险中的交互作用。

主要发现

  • 结节恶性风险可分层为四个CU评分:极低危<3%、低危≥3%且<30%、高危≥30%且<90%、极高危≥90%。
  • 在非诊断性、良性及意义未明的不典型/意义未明的滤泡性病变细胞学结果的结节中,低 suspicion 超声模式(K-TIRADS 3)显著降低恶性风险(p分别为0.003、0.013和0.027)。
  • 在非诊断性、良性及意义未明的不典型/意义未明的滤泡性病变细胞学结果的结节中,高 suspicion 超声模式(K-TIRADS 5)显著增加恶性风险(p≤0.001)。
  • Bethesda 1或4细胞学结果未显著改变任何K-TIRADS的恶性风险(p分别≥0.518和≥0.137)。
  • Bethesda 2细胞学结果降低而Bethesda 5或6细胞学结果增加K-TIRADS 3、4、5的恶性风险(p≤0.001)。

关键数值与推荐

  • CU评分四级:极低危<3%、低危≥3%且<30%、高危≥30%且<90%、极高危≥90%。

临床怎么用

  • 作者认为所提出的CU评分系统可能有助于细针穿刺后的甲状腺结节管理。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The malignancy risk of a cytology diagnosis may depend on the ultrasonography (US) patterns of thyroid nodules, and management should be determined by the combined malignancy risk of fine-needle aspiration (FNA) cytology and US patterns. This study was performed to develop a clinically applicable cytology-ultrasonography (CU) scoring system for malignancy risk stratification based on FNA cytology and US patterns, according to the Korean-Thyroid Imaging Reporting and Data System (K-TIRADS). METHODS: This retrospective Institutional Review Board-approved study included 1651 thyroid nodules (≥1 cm) with final diagnoses. The malignancy risk was assessed of the combined results of FNA cytology and the K-TIRADS for the development of the CU system. The interaction between FNA cytology and US pattern (K-TIRADS) in the malignancy risk of nodules was investigated by using a binominal test. RESULTS: The malignancy risk of nodules could be stratified into four CU scores (very low risk, <3%; low risk, ≥3%, <30%; high risk, ≥30%, <90%; very high risk, ≥90%). In nodules with non-diagnostic, benign, and atypia of undetermined significance/follicular lesion of undetermined significance cytology results, low-suspicion US pattern (K-TIRADS 3) significantly decreased the malignancy risk of nodules (p = 0.003, 0.013, and 0.027, respectively), and a high-suspicion US pattern (K-TIRADS 5) significantly increased the malignancy risk of nodules (p ≤ 0.001). A Bethesda 1 or 4 cytology result did not significantly change the malignancy risk of any K-TIRADS (p ≥ 0.518 and p ≥ 0.137, respectively). A Bethesda 2 cytology result decreased and a Bethesda 5 or 6 cytology result increased the malignancy risk of K-TIRADS 3, 4, and 5 (p ≤ 0.001). A Bethesda 3 cytology result increased the malignancy risk of K-TIRADS 3 and 4 (p < 0.001 and p = 0.024, respectively). CONCLUSION: The malignancy risk of thyroid nodules can be stratified by the CU risk-stratification system, based on FNA cytology and the K-TIRADS. The proposed CU scoring system may be helpful in the management of thyroid nodules after FNA.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Hong MJ, Na DG, Baek JH, et al. Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System. Thyroid. 2017. PMID: 28463597. doi:10.1089/thy.2016.0603

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。